Announced Tue, 14 Jul · 10:26 IST
Promoter Ravi Agrawal releases pledge on 2,600 Ajanta Pharma shares
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.7%1-day move
₹3425.10
prior close
₹3373.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.0+0.0+0.5+0.7+0.8-0.4+1.2+4.4+0.2————
Up moveDown movePending
AI summary
Ravi Agrawal, trustee of Ravi Agrawal Trust and promoter of Ajanta Pharma, released a pledge on 2,600 equity shares on 9 July 2026. The reason cited is excess pledge. His encumbered holding fell from 15,37,696 shares (1.23%) to 15,35,096 shares (1.23%). The pledge was held with HSBC Direct Invest Financial Services as lender.
Likely market impact
Small pledge release due to excess collateral. Negligible impact on promoter shareholding or stock price.